• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
MRC Laboratory of Molecular Biology

MRC Laboratory of Molecular Biology

One of the world's leading research institutes, our scientists are working to advance understanding of biological processes at the molecular level - providing the knowledge needed to solve key problems in human health.

  • Home
  • About LMB
  • Research
  • Research Groups
  • Students
  • Recruitment
  • Life at the LMB
  • Achievements
  • News & Events
Home > Research Leaders > H to M > Patrycja Kozik
pnac

Patrycja Kozik

Dendritic cells and initiation of immune responses

Dendritic cells (DCs) play a key role in initiation of cytotoxic immune responses against pathogens and tumours. In order to prime the relevant T cells, DCs acquire antigens from infected or cancer cells and process them for presentation on MHC class I molecules (Figure 1).

Figure 1. Antigen cross-presentation and initiation of cytotoxic immune responses by dendritic cells.
Figure 1. Antigen cross-presentation and initiation of cytotoxic immune responses by dendritic cells.

 

We are interested in the signalling events, membrane trafficking pathways, and transcriptional programmes that control processing of captured antigens and the efficiency of T cell priming (Figure 2). We employ proteomics, transcriptomics and CRISPR-Cas9-based genetic screening strategies to identify the players involved and to build a detailed picture of the molecular events that occur in DCs following antigen uptake.

Figure 2. Intracellular events in dendritic cells that follow antigen capture.
Figure 2. Intracellular events in dendritic cells that follow antigen capture.

We also aim to understand how intracellular membrane trafficking and signalling pathways are modulated by danger signals associated with viral infection or tumour environment. These signals regulate the efficiency of antigen processing as well as expression of co-stimulatory molecules and, ultimately, determine whether the DC-T cell interaction results in an immunogenic response or, conversely, promotes tolerance.

In parallel, we seek to use the knowledge of DC biology to identify novel immunotherapeutic strategies that could elicit potent and long-lasting tumour-specific immune responses.

Group Members

  • Lorena Boquete Vilarino
  • Romina Koiffman
  • Patrycja Krawczyk
  • Marco Laub
  • Pablo Rodriguez
  • Benjamin Tuck

Primary Sidebar

Research Leaders

  • A to G
    • Matteo Allegretti
    • Radu Aricescu
    • David Barford
    • Buzz Baum
    • Anne Bertolotti
    • Tanmay Bharat
    • Mariann Bienz
    • Simon Bullock
    • Albert Cardona
    • Andrew Carter
    • Jason Chin
    • Gerry Crossan
    • Emmanuel Derivery
    • Michel Goedert
    • Julian Gough
    • Ingo Greger
  • H to M
    • Michael Hastings
    • Ramanujan Hegde
    • Richard Henderson
    • Philipp Holliger
    • Leo James
    • Gregory Jefferis
    • Patrycja Kozik
    • Madeline Lancaster
    • Jan Löwe
    • Kate McDole
    • Andrew McKenzie
    • Harvey McMahon
    • Liz Miller
    • Sean Munro
    • Garib Murshudov
  • N to S
    • Kelly Nguyen
    • John O’Neill
    • Lori Passmore
    • Lalita Ramakrishnan
    • Venki Ramakrishnan
    • Felix Randow
    • Jing Ren
    • Christopher Russo
    • Benjamin Ryskeldi-Falcon
    • Julian Sale
    • William Schafer
    • Sjors Scheres
    • Marta Shahbazi
    • John Sutherland
  • T to Z
    • Chris Tate
    • Marco Tripodi
    • Ana Tufegdžić Vidaković
    • Roger Williams
    • Joseph Yeeles
    • Suyang Zhang
    • Marta Zlatic
  • Emeritus
    • Brad Amos
    • Tony Crowther
    • Phil Evans
    • Alan Fersht
    • Michael Gait
    • Rob Kay
    • John Kendrick-Jones
    • John Kilmartin
    • Peter Lawrence
    • Andrew Leslie
    • David Neuhaus
    • Hugh Pelham
    • Daniela Rhodes
    • Murray Stewart
    • Andrew Travers
    • Nigel Unwin
    • Greg Winter
  • LMB Fellows
  • Molecular Immunity Unit

Search

  • Privacy & Cookies
  • Contact Directory
  • Freedom of Information
  • Site Map
Find Us
©2023 MRC Laboratory of Molecular Biology,
Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0QH, UK. 01223 267000

The MRC is part of UK Research and Innovation

Contact Us